# A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults

> **NCT05907395** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 30 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-07293893
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05907395
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-09
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-03-22
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05907395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05907395, "A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05907395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*